Pacira BioSciences Management
Management criteria checks 0/4
Pacira BioSciences' CEO is Frank Lee, appointed in Jan 2024, has a tenure of 1.08 years. directly owns 0.051% of the company’s shares, worth €603.77K. The average tenure of the management team and the board of directors is 1.8 years and 1.3 years respectively.
Key information
Frank Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.05% |
| Management average tenure | 1.8yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO
Frank Lee (56 yo)
1.1yrs
Tenure
Mr. Frank D. Lee served as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021 until September 2024. He is Independent Director of Bausch Health Companies Inc. from May 14, 2024. He i...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Operating Officer | 2.8yrs | US$1.53m | 0.026% € 304.6k | |
| Chief Administrative Officer & Secretary | 10.3yrs | US$1.60m | 0% € 0 | |
| Advisor | 1.1yrs | US$6.88m | 0.51% € 6.0m | |
| Executive Officer | less than a year | US$1.43m | 0.059% € 696.5k | |
| Chief Medical Officer | 3.6yrs | US$1.59m | 0.042% € 497.0k | |
| CEO & Director | 1.1yrs | no data | 0.051% € 603.8k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Principal Accounting Officer & Senior VP of Finance | 12.9yrs | US$288.82k | 0.011% € 126.5k | |
| Head of Investor Relations | no data | no data | no data | |
| Chief Legal & Compliance Officer | 3.2yrs | US$2.05m | 0.028% € 327.1k | |
| Chief Manufacturing Officer | 1.8yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data |
1.8yrs
Average Tenure
54yo
Average Age
Experienced Management: 82P's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.1yrs | no data | 0.051% € 603.8k | |
| Independent Chair of the Board | 13.7yrs | US$364.01k | 0.027% € 313.0k | |
| Independent Director | 11.7yrs | US$373.01k | 0.043% € 499.6k | |
| Independent Director | 5.4yrs | US$325.01k | 0.011% € 133.6k | |
| Independent Director | 1.3yrs | US$427.86k | 0% € 0 | |
| Independent Director | 1.3yrs | US$426.45k | 0.011% € 124.8k | |
| Independent Director | 1.3yrs | US$427.16k | 0% € 0 | |
| Independent Director | 7.7yrs | US$349.01k | 0.020% € 234.8k | |
| Independent Director | 1.3yrs | US$427.16k | 0.0043% € 50.8k |
1.3yrs
Average Tenure
61.5yo
Average Age
Experienced Board: 82P's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/03 08:50 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pacira BioSciences, Inc. is covered by 34 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Silver | Barclays |
| Balaji Prasad | Barclays |
| Balaji Prasad | Barclays |